Investing Profile

Vincent Ossipow

InvestorVC
Partner at Omega Funds at Omega Funds
omegafunds.comSwitzerland
Photo of Vincent Ossipow, Partner at Omega Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
5842 CONNECTIONS
Hotmail Network
5842 CONNECTIONS
Danish Ministry of Justice Network
1114 CONNECTIONS
Danish Ministry of Justice Network
1114 CONNECTIONS
Georgetown University Network
207 CONNECTIONS
cb
Omega Funds Partner
$100K - $5.0M
$1.5M
5
CompanyStageDateRound SizeTotal Raised
Callio Therapeutics
Series AMar 2025$190M
$190M
Co-investors: Brian Matesic (Norwest Venture Partners), Daniel Estes (Frazier Life Sciences)
Aerium Therapeutics
Series AMar 2022
Co-investors: Michael Powell (Omega Funds), Stephen Knight (F-Prime Capital (formerly Fidelity Biosciences))
FoRx Therapeutics
SeedApr 2020$11M
$110M
Co-investors: Vincent Brichard (EQT Group), Florian Müllershausen (Novartis Venture Fund), Therese Liechtenstein (4BIO Capital), Denis Patrick (Pfizer Venture Investments)
Andrew Alliance
Series CJun 2018$14M
Series BAug 2014
$14M
Member of the Board of Directors Danish Ministry of JusticePresent
Chief Scientific Officer (CSO) Danish Ministry of JusticePresent
Postdoctoral Fellow National Cancer Institute (NCI)Present
Financial Analyst Pictet GroupPresent
Faculty Member Université de GenèvePresent
Investment Manager Sectoral Asset ManagementPresent
Member of the Board of Directors HotmailPresent
Chief Scientific Officer (CSO) HotmailPresent
Partner Private Equity Sectoral Asset ManagementPresent
Partner Omega FundsPresent
Partner at Omega Funds Omega FundsPresent
University of Geneva Doctor of Philosophy (Ph.D.) Molecular Biology
Georgetown University Certificate International Finance
Sign in with Google →
Sign in with Google →